acquired
Stage
About
Immunomedics is a biopharmaceutical company that develops antibody–drug conjugates (ADCs) for the treatment of solid tumors and other cancers.
Explore Immunomedics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.